The histone deacetylase inhibitor CT-101 flips the switch to fetal hemoglobin expression in sickle cell disease mice.
The most common hemoglobin disorder worldwide is sickle cell disease (SCD) caused by a point mutation in the adult β-globin gene. As a result, hemoglobin S production occurs leading to clinical symptoms including vaso-occlusive pain, organ damage, and a shortened lifespan. Hydroxyurea is the only FD...
Saved in:
| Main Authors: | Mayuko Takezaki, Biaoru Li, Hongyan Xu, Nikhil Patel, Rudolf Lucas, Ryan E Cerbone, Sivanagireddy Koti, Clifford L Hendrick, Louis H Junker, Betty S Pace |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0323550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The functional interactome landscape of the human histone deacetylase family
by: Preeti Joshi, et al.
Published: (2013-06-01) -
Research advances of histone deacetylases in acute kidney injury
by: Deng Fang-jing, et al.
Published: (2022-04-01) -
Histone deacetylase in inflammatory bowel disease: novel insights
by: Chunxiao Li, et al.
Published: (2025-02-01) -
Regulation of cardiovascular diseases by histone deacetylases and NADPH oxidases
by: Hui Yan, et al.
Published: (2024-11-01) -
Mechanisms of resistance to histone deacetylase inhibitors in acute leukemia
by: Mohammad Amin Akbarzadeh, et al.
Published: (2024-12-01)